Tarsus Pharmaceuticals Inc (TARS)
Cost of Revenue
$57.03M
TTM · Period ending: · USD
TARS Cost of Revenue
Latest reported$57.03Mperiod ending
Latest reported$57.03Mperiod ending
TARS TTM Cost of Revenue ($20.00K → $57.03M)
TTM cost of revenue
High-resolution chart · PNG
TARS cost of revenue history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Cost of Revenue (USD) |
|---|---|
| 57,029,000 | |
| 51,153,000 | |
| 46,968,000 | |
| 40,967,000 | |
| 19,616,000 | |
| 16,383,000 | |
| 12,826,000 | |
| 9,116,000 | |
| 6,251,000 | |
| 3,563,000 | |
| 2,164,000 | |
| 1,348,000 | |
| 1,182,000 | |
| 1,388,000 | |
| 1,166,000 | |
| 742,000 | |
| 596,000 | |
| 811,000 | |
| 2,075,000 | |
| 2,099,000 | |
| 2,034,000 | |
| 1,297,000 | |
| 0 | |
| 0 | |
| 20,000 | |
| 20,000 | |
| 20,000 |